Ibrutinib provides favourable survival outcomes in patients with comorbidities versus established therapies. (10th February 2019) - Burger, Jan A.; Cramer, Paula; Barr, Paul M.; Dilhuydy, Marie‐Sarah; Mato, Anthony; Byrd, John C.; Chang, Stephen; Graef, Thorsten; Lin, Tony; Tedeschi, Alessandra